FDA To Expedite Review Of Fertility, 8 Other Drugs As Part Of TrumpRx MFN Deal

By Maaisha Osman, Amy Lotven / October 16, 2025 at 7:33 PM

FDA will fast-track review of EMD Serono’s fertility drug in addition to drugs from eight other companies under the Commissioner’s National Priority Voucher program, which incentivizes companies to make their products more affordable and take other steps in the “national interest.”


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.